https://www.selleckchem.com/pr....oducts/sanguinarine-
Organ transplantation is life saving for patients with end-stage organ disease and results in overall improved survival and quality of life. Despite this, organ transplant patients have a two-fold higher risk of malignancy compared with the general population, secondary to, among other risk factors, immunosuppression, age and oncogenic viruses (1). The most common cancers include non-Hodgkin's lymphoma and cancer of the lung, liver and kidney. Risk is increased for malignancies related to infection (Kaposi's sarcoma, anal
Like
Comment
Share
